Please assess the completion status of the following clinical trial:

Trial Title: AZD7325 Japan Multiple Ascending Dose (MAD) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Japanese subjects~Exclusion Criteria:~* Significant illness, as judged by the investigator, within 2 weeks of Day 1~* Enrollment in another concurrent investigational study or intake of an investigational drug within 4 months prior to the screening visit~* Blood loss in excess of 200 mL within 30 days of Day 1, in excess of 400 mL within 90 days of Day 1, or in excess of 1200 mL within 1 year of Day 1~* Clinically relevant abnormalities in physical examinations, vital signs, clinical chemistry, hematology or urinalysis as judged by the investigator and/or sponsor

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Low dose or placebo, twice daily
- 2 (Type: EXPERIMENTAL): Low dose or placebo, once daily
- 3 (Type: EXPERIMENTAL): Middle dose or placebo, twice daily
- 4 (Type: EXPERIMENTAL): High dose or placebo, once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).